Evolent Health Inc stock (US30050B1017): valuation metrics in focus after recent share price recovery

Evolent Health Inc shares have stabilized after recent volatility, putting the focus on valuation metrics such as market capitalization and price-to-earnings ratios as investors reassess the US health technology provider.

Evolent Health Inc shares continue to trade in a lower range compared with last year, but recent data show a modest recovery that has put the spotlight back on valuation rather than short-term swings.

According to Robinhood data, the stock most recently changed hands at USD 4.37 on Nasdaq, giving the company a market capitalization of about USD 492.1 million as of 06/04/2026 and implying a negative price-to-earnings ratio of -0.79 based on trailing results, underscoring that the business is still loss-making on a net income basis.Robinhood as of 06/04/2026

In its home market of the United States, Evolent Health is listed on Nasdaq under the ticker EVH and is generally classified by data providers as part of the healthcare technology or information technology universe, reflecting its focus on technology-enabled services for medical cost management and value-based care programs.wallstreet-online.de as of 05/26/2026

As of: 05/06/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: EVH
• Sector/industry: Healthcare technology / information technology services
• Headquarters/country: Arlington, United States
• Core markets: United States value-based care and health plan customers
• Key revenue drivers: Technology-enabled services and clinical solutions for payers and providers
• Home exchange/listing venue: Nasdaq (EVH)
• Trading currency: USD

Evolent Health Inc: core business model

Evolent Health Inc operates as a US-based healthcare technology and services company that partners with health plans and providers to design and manage value-based care arrangements and specialty care programs, generating revenue primarily from long-term service contracts and performance-based fees tied to medical cost savings.

Valuation metrics and multiples for Evolent Health Inc

With the stock at USD 4.37 and a market capitalization around USD 492.1 million as of 06/04/2026, Evolent Health currently trades on a negative price-to-earnings multiple of about -0.79, reflecting that the company is loss-making over the most recently reported period while still being valued at just under half a billion dollars by equity markets.Robinhood as of 06/04/2026

Data compiled by the German platform wallstreet-online.de indicate that the registered A shares of Evolent Health have a market capitalization of roughly EUR 371.19 million and have fallen about 47.50% over the past twelve months as of 05/26/2026, placing the company among the weaker performers in its segment over that period despite a positive performance of about 6.33% over the most recent month.wallstreet-online.de as of 05/26/2026

On the same platform, the shares were quoted at EUR 3.30 on 05/26/2026 on a German trading venue, which represented a one-day decline of about 4.07% but still left the price roughly 81.62% above the 52-week low, even as it remained around 67.06% below the 52-week high, highlighting the wide trading range the stock has experienced over the past year and the degree of volatility involved for investors.wallstreet-online.de as of 05/26/2026

Conclusion

Evolent Health Inc shares are trading at around USD 4.37 on Nasdaq and EUR 3.30 on German venues based on late-May and early-June quotes, levels that imply a sub-USD 500 million market capitalization and a negative earnings multiple, pointing to a market that is still cautious about the pace of the companys profitability progress.Robinhood as of 06/04/2026

Valuation metrics from US and European data providers show that, despite some recent month-on-month share price gains, the stock remains far below its 52-week high and has delivered a sharply negative one-year performance, which keeps investor attention firmly on whether management can translate its technology-enabled healthcare platform into more consistent earnings over time.wallstreet-online.de as of 05/26/2026

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.